Meeting
2017 Genitourinary Cancers Symposium
Humanized mice (humice) carrying patient-derived xenograft (PDX) as a platform to develop immunotherapy in bladder cancer (BCa).
Authors
Chong-xian Pan
UC Davis Comprehensive Cancer Center, Sacramento, CA
Chong-xian Pan , Wei Shi , Ai-Hong Ma , Hongyong Zhang , Primo Lara Jr., James G. Keck , Karolina Palucka , Susan D. Airhart , Ralph deVere White
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Prostate Cancer,Urothelial Carcinoma,Prostate Cancer
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 381)
DOI
10.1200/JCO.2017.35.6_suppl.381
Abstract #
381
Poster Bd #
H18
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Patient-derived tumor xenografts in humanized NSG-SGM3 mice: a new immuno-oncology platform.
First Author: Li-Chin Yao
Poster
2021 ASCO Annual Meeting
Multi-center randomized study of pembrolizumab/carboplatin versus carboplatin alone in patients with chest wall disease from breast cancer: TBCRC 044.
First Author: Neelima Vidula
Poster
2024 ASCO Breakthrough
Efficacy and safety of surufatinib plus toripalimab in previously treated advanced tumors progressing after immunotherapy.
First Author: Panpan Zhang
First Author: Igor Tsaur